We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

3 cheap FTSE 100 stocks to buy and hold for 10 years 

These FTSE 100 stocks are not the cheapest, but they are cheaper than many other index constituents. And they have also given great returns over time. 

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Cheap stocks are getting incredibly hard to come by among FTSE 100 constituents. As the stock markets stay buoyant, share prices are rising fast too. But there are still some stocks that can be seen as relatively cheap. To figure out which ones these are, I first consider the price-to-earnings (P/E) ratio for the FTSE 100 index as a whole. This is around 20 times. 

Many of the stocks that are performing well right now have P/Es well over this level. But there are some around that have lower P/Es too. This is important, because it suggests that these stocks could be undervalued compared to the average FTSE 100 stock. This in turn means that their share prices could rise in the near future. 

XXX

Hikma Pharmaceuticals: beaten down FTSE 100 stock

One such stock is the pharmaceuticals company Hikma Pharmaceuticals. It has a P/E of 15.2 times, which is not terribly low, but is still lower than average. This leaves some room for growth. But I believe that there could be even more upside considering that it has just delivered robust results.

Moreover, its share price has come off in the past year. As I write, it is down by more than 12% from the same time last year. I think this is a good reason to buy the stock, which has given some 300% return over the last 10 years, albeit with a fair bit of fluctuation in the intervening period. It is definitely a stock on my wish list right now. 

Persimmon: attractive dividend yields

The FTSE 100 house builder Persimmon has a similar story. It has a relatively low P/E of 11.2 times, at least partly because its share price has gone nowhere in the past year. In fact, it has shown a small decline. But over the past decade, it has been an excellent stock to hold. It has grown by more than 500% over this time! And here is another good bit: it also has an attractive dividend yield of 6.5%.

The outlook for property stocks is a bit iffy for next year considering that supportive government policies are being withdrawn. Yet, over the long term, I think this is a winning stock, even if it sees ups and downs during the course of the business cycle. I bought the stock for the long term for this reason a few months ago. 

3i: impressive returns

Last is the investment company 3i, which has given the best returns among the three stocks in consideration here, of almost 700% over the last 10 years. It has also risen some 30% over the past year, though its P/E remains low at 4.5 times. If I consider its price to net asset value, the more popular indicator for measuring investment companies’ value, it does appear a bit overvalued.

Still, it recently delivered good results and is also optimistic about the future, which suggests to me that at a buoyant time for the stock markets, its share price could continue to rise. The stock is a buy for me.

Manika Premsingh owns shares of Persimmon. The Motley Fool UK has recommended Hikma Pharmaceuticals. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »